PEDEVCO CORP. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by PEDEVCO CORP. on August 29, 2024. The filing reports on events occurring at the Company's 2024 Annual Meeting of Stockholders, including the election of directors, ratification of auditors, approval of an equity plan amendment, and the granting of restricted stock awards to non-employee directors.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. This report focuses on corporate governance and equity compensation events rather than financial performance results.
Material Changes and Corporate Actions
- Equity Plan Amendment: Stockholders approved the First Amendment to the 2021 Equity Incentive Plan, increasing the maximum number of shares available for issuance from 8,000,000 to 13,000,000 shares.
- Director Compensation: On August 29, 2024, the Company granted restricted stock awards to two non-employee directors:
- 125,000 shares to Chairman John Scelfo (vesting July 12, 2025).
- 85,000 shares to Director H. Douglas Evans (vesting September 27, 2025).
- Board Elections: Three director nominees (John J. Scelfo, Dr. Simon G. Kukes, and H. Douglas Evans) were elected to the Board of Directors.
- Auditor Ratification: Marcum LLP was ratified as the independent registered public accounting firm for the 2024 fiscal year.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or specific risk factors. The document notes that the description of the Restricted Shares Grant Agreements and the First Amendment is qualified by reference to the full text of those agreements and the Definitive Proxy Statement filed on July 12, 2024.
Key Facts for Investor Verification
- Verify the total number of shares outstanding (89,285,267 as of the July 1, 2024 record date) to assess the dilution impact of the new 13,000,000 share equity plan cap.
- Review the voting results for the Equity Plan Amendment, which received 66,871,063 votes "For" versus 786,552 "Against."
- Confirm the vesting conditions for the new director awards, which are contingent on the recipients remaining on the Board of Directors on the vesting dates.
- Check the Definitive Proxy Statement (Schedule 14A) for detailed terms of the 2021 Equity Incentive Plan amendment.